Robert Alpern

Robert Alpern

Director/Board Member at TRICIDA, INC.

Net worth: 11 M $ as of 31/05/2026

75 year
Consumer Services
Health Technology
Health Services

Profile

Robert J.
Alpern
is currently an Independent Director at Tricida, Inc. since 2013, a Professor at Medicine Hat College, President of Austin Investment Advisors since 2004, and a Professor at Yale School of Medicine since 2020.
Former roles include Independent Director at AbbVie, Inc. from 2013 to 2026, Independent Director at Abbott Laboratories from 2008 to 2026, Trustee at Yale-New Haven Hospital, Inc. from 2005 to 2020, President of the American Society of Nephrology, and Dean at The University of Texas Southwestern Medical Center from 1998 to 2004.
Education includes a doctorate from Pritzker School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2026 35,646 ( 0% ) 8 M $ 31/05/2026
31/03/2026 40,798 ( 0% ) 3 M $ 31/05/2026

Robert Alpern active positions

CompaniesPositionStart
TRICIDA, INC. Director/Board Member 01/10/2013
Austin Investment Advisors
President 01/01/2004
Corporate Officer/Principal 01/06/2004
Corporate Officer/Principal -

Former positions of Robert Alpern

CompaniesPositionEnd
ABBVIE INC. Director/Board Member 08/05/2026
ABBOTT LABORATORIES Director/Board Member 24/04/2026
Director/Board Member 01/01/2020
Corporate Officer/Principal 01/05/2004
President -
See the detail of Robert Alpern's experience

Training of Robert Alpern

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Health Services

Consumer Services

Austin Investment Advisors

Consumer Services

Consumer Services

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!